E.A. Friedman – författare
Visar alla böcker från författaren E.A. Friedman. Handla med fri frakt och snabb leverans.
12 produkter
12 produkter
1 657 kr
Skickas inom 10-15 vardagar
After a decade or longer, approximately one-third of individuals with either Type 1 or Type 2 diabetes commence a downhill course in which decreasing renal function and failing vision define a renal-retinal syndrome, dominating all aspects of life and presaging early death. Only a generation ago, survival after onset of end-stage renal disease (ESRD) in diabetes was limited because rehabilitation was pre-empted by blindness, limb amputation, stroke, and heart disease. By 1998, however, team management has improved the outlook, with preserved sight and return to work and home responsibilities, usually for a decade or longer, following kidney transplantation and laser photocoagulation. Recognition of the critical requirement for blood pressure regulation and metabolic control are central themes in management. In this book, the accomplishments of ophthalmologists, nephrologists, diabetologists, transplant surgeons, and basic scientists are blended into a strategic approach that may be readily applied by all those caring for diabetic patients.Each of 21 presentations suitable for primary care physicians, as well as for subspecialists concerned with macrovascular and microvascular complications of diabetes, is placed in perspective by an introductory editorial analysis. Promising near-term innovative therapies, including insertion of genetically engineered beta cells or polymer-coated islets of Langerhans, interdiction of kinins that promote retinal angiogenesis, and prevention of synthesis of advanced glycosylated endproducts (AGEs), are presented in detail. While comprehensive care of diabetic patients reflects multiple incremental advances which afford major benefit, this text envisions further remarkable changes likely to suppress and possibly entirely prevent the diabetic renal-retinal syndrome.
Strength and Compassion in Kidney Failure
Writings of Mildred (Barry) Friedman Professional Kidney Patient
Inbunden, Engelska, 1998
1 657 kr
Skickas inom 10-15 vardagar
Written from the perspective of the joy of celebrating life rather than lamenting the scourge of chronic illness, this collection of medical columns, short stories, and letters recounts the tale of coping, surviving and prevailing. Starting out as a medical technician, wife, and mother faced with progressive loss of sight and ambulation, Mildred Barry Friedman devised strategies for using her intellect to benefit other patients and medical professionals. Free from self pity and permeated by hope, enthusiasm and the belief that there was much to be accomplished, Friedman proved to be a keen observer of the sense and nonsense comprising her therapeutic regimen for diabetes, Addison's disease, and renal failure. Especially helpful are Friedman's hints for dealing with the necessity of diet and time change during travel and activity while under treatment with insulin. Reading these short stories reveals a sense of humour and a glint of impish satisfaction in just being alive.
Strength and Compassion in Kidney Failure
Writings of Mildred (Barry) Friedman Professional Kidney Patient
Häftad, Engelska, 1998
1 657 kr
Skickas inom 10-15 vardagar
Written from the perspective of the joy of celebrating life rather than lamenting the scourge of chronic illness, this collection of medical columns, short stories and letters recounts the tale of coping, surviving, and prevailing. Starting out as a medical technician, wife, and mother faced with progressive loss of sight and ambulation, Barry Friedman devised strategies for using her intellect to benefit other patients and medical professionals. Free from self pity and permeated by hope, enthusiasm, and the belief that there was much to be accomplished, Friedman proved to be a keen observer of the sense and nonsense comprising her therapeutic regimen for diabetes, Addison's disease and renal failure. Especially helpful are Friedman's hints for dealing with the necessity of diet and time change during travel and activity while under treatment with insulin. Reading these short stories reveals a sense of humour and a glint of impish satisfaction in just being alive.
1 107 kr
Skickas inom 10-15 vardagar
Once dialysis treatment, in 1960, permitted life prolongation for some but not all patients in kidney failure, an `ethical genie' was released. The introduction of peritoneal dialysis and kidney transplantation compounded the physician's dilemma by underscoring those left untreated. Who should be selected for uremia therapy? Should exclusion from treatment be properly delegated to administrators or physicians, or better left to a committee? Are some candidates more worthy than others? As examples: Do Presidents and Kings warrant priority in cadaver organ allocation over ordinary citizens? Are rich people more deserving than the poor? Is it ethical to choose a younger over an older patient? Can children and/or mentally incompetent persons serve as living organ donors? Is it proper to market organs under controlled circumstances? Eli A. Friedman, an experienced nephrology training program director, and Medical Advisor to the American Association of Kidney Patients, has collected 24 difficult cases that focus on these and other vexing though common stressful issues faced by those who manage kidney patients. Using a novel approach to each case, the opinions of lawyers, nephrologists, patients, and a transplant surgeon are proffered sequentially. Friedman asks and then answers searching questions arising from the debate. The quality of information presented is positively flavored by the fact that three of the respondents (one an attorney) are kidney transplant recipients. Members of the kidney team, those immersed in seeking truth in medical ethics, and all participating in exploring the legality or ethical basis of organ replacement will find this book pertinent to their effort.
1 107 kr
Skickas inom 10-15 vardagar
Increasingly, medicine in general, and nephrology specifically, is based on clinical trials and verifiable presumption. Still, however, much of everyday clinical practice is the consensus of pundits and experts unable to validate their suggestions beyond personal bias. In this volume, several core beliefs in renal medicine are examined and challenged. Starting as assignments for nephrology fellows, this book grew out of surprising "revelations" indicating that "the emperor has no clothes". The book should be suitable as a stimulus for discussions for nephrologists, internists, house staff, and medical students.
1 107 kr
Skickas inom 10-15 vardagar
Increasingly, medicine in general, and nephrology specifically, is based on clinical trials and verifiable presumption. Still, however, much of everyday clinical practice is the consensus of pundits and experts unable to validate their suggestions beyond personal bias. In this volume, several core beliefs in renal medicine are examined and challenged. Starting as assignments for nephrology fellows, this book grew out of surprising "revelations" indicating that "the emperor has no clothes". The book should be suitable as a stimulus for discussions for nephrologists, internists, house staff, and medical students.
1 107 kr
Skickas inom 10-15 vardagar
Fresh insights into the pathogenic mechanisms by which hyperglycaemia induces tissue and organ injury are the basis for rapidly evolving therapies in diabetes. Especially promising as targets for intervention are products of oxidative stress, including kinins and growth factors. Improving results of renal replacement regimes now incorporating pancreatic islet transplants are able to delay and prevent end-organ damage in diabetic individuals. This text looks at the evolving story of the taming of diabetes, which should be of direct concern to nephrologists, endocrinologists, ophthalmologists, primary care physicians and medical students.
557 kr
Skickas inom 10-15 vardagar
Diabetic nephropathy is a tragic illness. Its often insidious onset in the insulin dependent (type I) diabetic, typically a young adult, heralds the last act in the course of a disease that will increasingly become the dominant preoccupation in the patient's shortened life. For most type II diabetics, the beginning of clinical renal insufficiency is but a phase in a continuous deterioration that affects the integrity ofjob, marriage, and family. The nephropathic diabetic is hypertensive, has worsening retinopathy, and more often than not, is also plagued by peripheral vascular insufficiency, heart disease, gastrointestinal malfunction, and deepening depression. Until the 1980's, few type I diabetics who became uremic (because ofdiabetic nephropathy) lived for more than two years. Hardly any attained true rehabilitation. This dismal prognosis is changing substantially for the better. Research in diabetes has resulted in striking advances at both ends of the type I diabetic's natural history. In one exciting clinical trial now underway in London, Ontario, halfofchildhood diabetics treated with cyclosporine within six weeks of onset evince"permanent" disappearanceofhyperglycemia and the need for insulin. At the otherendofthe natural historyofdiabetes for the nephropathic patientwith worsening eye disease (renal-retinal syndrome), who receives a kidney transplant, patient and graft survival, two years after cadaveric kidney transplantation in type I diabetics is now equal to that of the nondiabetic.
1 107 kr
Skickas inom 10-15 vardagar
Fresh insights into the pathogenic mechanisms by which hyperglycemia induces tissue and organ injurt are the basis for rapidly evolving promising therapies in diabetes. Especially promising as targets for intervention are products of oxidative stress, including kinins and growth factors. Improving results of renal replacement regimes now incorporating pancreatic islet transplants are able to delay and prevent end-organ damage in diabetic individuals. The evolving story of the taming of diabetes is of direct concern to nephrologists, endocrinologists, ophthalmologists, primary care physicians and medical students.
Del 35 - Developments in Nephrology
Death on Hemodialysis: Preventable or Inevitable?
Häftad, Engelska, 2012
557 kr
Skickas inom 10-15 vardagar
Death on Hemodialysis: Preventable or Inevitable? presents the transactions of the Brooklyn meeting, held in April 1993, including an analysis by Scribner and Schreiner and an introduction by Edmund Bourke. Authors include the heads of dialysis registries for Japan, Europe, and the United States, as well as protagonists of dialyser reuse and short dialysis times. Enthusiasts championed the determination of adequacy of dialysis by formulae or by clinical assessment. All chapters are direct and forceful. The reader will be able to judge the data on what are key controversies in planning dialysis protocols and schedules.
989 kr
Skickas inom 10-15 vardagar
Once dialysis treatment, in 1960, permitted life prolongation for some but not all patients in kidney failure, an `ethical genie' was released. The introduction of peritoneal dialysis and kidney transplantation compounded the physician's dilemma by underscoring those left untreated. Who should be selected for uremia therapy? Should exclusion from treatment be properly delegated to administrators or physicians, or better left to a committee? Are some candidates more worthy than others? As examples: Do Presidents and Kings warrant priority in cadaver organ allocation over ordinary citizens? Are rich people more deserving than the poor? Is it ethical to choose a younger over an older patient? Can children and/or mentally incompetent persons serve as living organ donors? Is it proper to market organs under controlled circumstances? Eli A. Friedman, an experienced nephrology training program director, and Medical Advisor to the American Association of Kidney Patients, has collected 24 difficult cases that focus on these and other vexing though common stressful issues faced by those who manage kidney patients. Using a novel approach to each case, the opinions of lawyers, nephrologists, patients, and a transplant surgeon are proffered sequentially. Friedman asks and then answers searching questions arising from the debate. The quality of information presented is positively flavored by the fact that three of the respondents (one an attorney) are kidney transplant recipients. Members of the kidney team, those immersed in seeking truth in medical ethics, and all participating in exploring the legality or ethical basis of organ replacement will find this book pertinent to their effort.
1 657 kr
Skickas inom 10-15 vardagar
After a decade or longer, approximately one-third of individuals with either type 1 or type 2 diabetes commence a downhill course in which decreasing renal function and failing vision define a Renal-Retinal Syndrome, dominating all aspects of life and presaging early death. Only a generation ago, survival after onset of end-stage renal disease (ESRD) in diabetes was limited because rehabilitation was preempted by blindness, limb amputation, stroke, and heart disease. By 1998, however, team management has improved the outlook, with preserved sight and return to work and home responsibilities, usually for a decade or longer, following kidney transplantation and laser photocoagulation. Recognition of the critical requirement for blood pressure regulation and metabolic control are central themes in management. In this unique book, the accomplishments of ophthalmologists, nephrologists, diabetologists, transplant surgeons, and basic scientists are blended into a strategic approach that may be readily applied by all those caring for diabetic patients. Each of twenty-one presentations suitable for primary care physicians, as well as for subspecialists concerned with macrovascular and microvascular complications of diabetes, is placed in perspective by an introductory editorial analysis. Promising near-term innovative therapies, including insertion of genetically engineered beta cells or polymer-coated islets of Langerhans, interdiction of kinins that promote retinal angiogenesis, and prevention of synthesis of advanced glycosylated endproducts (AGEs), are presented in detail. While comprehensive care of diabetic patients reflects multiple incremental advances that in sum afford major benefit, this text envisions further remarkable changes likely to suppress and possibly entirely prevent the Diabetic Renal-Retinal Syndrome.